CTOs on the Move

Raptor Pharmaceuticals

www.raptorpharma.com

 
Raptor is a NASDAQ-listed biopharmaceutical company with the mission to develop and commercialize life-altering therapeutics that treat debilitating and often fatal diseases. Raptor`s lead product, PROCYSBI (cysteamine bitartrate) delayed-release capsules, received FDA approval on April 30, 2013. The Company anticipates receiving a determination from the EMA regarding its PROCYSBI marketing application in the European Union in the second half of 2013. Raptor’s product pipeline may advance therapeutic options for additional indications. Raptor`s management team consists of repeat entrepreneurs with the experience to build a successful company.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Marketbase

Marketbase is a Herndon, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gemin

Gemin

Aeris Therapeutics Inc

Aeris Therapeutics Inc is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LifeSpan Biosciences

LifeSpan Biosciences is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Qiagen

Digene Corporation develops, manufactures and markets gene-based diagnostic tests for the screening, monitoring and diagnosis of human diseases. Its primary focus is in women's cancers and infectious diseases. The Company has applied its Hybrid Capture